Cisplatin Therapy Does Not Worsen Renal Function in Severe Antenatal Bartter Syndrome

by Welch, Thomas R., Shaffer, David R., Feldman, Darren R.
Published in Case Rep Nephrol Dial (2017)

Models of Self and Others and their Relation to Positive and Negative Caregiving Responses

by Morse, Jennifer Q., Shaffer, David R., Williamson, Gail M., Dooley, W. Keith, Schulz, Richard
Published 2011

Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate

by Shaffer, David R., Viale, Agnes, Ishiwata, Ryota, Leversha, Margaret, Olgac, Semra, Manova, Katia, Satagopan, Jaya, Scher, Howard, Koff, Andrew
Published 2005

Everolimus Combined With Gefitinib in Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I/II Results and Signaling Pathway Implications

by Rathkopf, Dana E., Larson, Steven M., Anand, Aseem, Morris, Michael J., Slovin, Susan F., Shaffer, David R., Heller, Glenn, Carver, Brett, Rosen, Neal, Scher, Howard I.
Published in Cancer (2015)

Differential exoprotease activities confer tumor-specific serum peptidome patterns

by Villanueva, Josep, Shaffer, David R., Philip, John, Chaparro, Carlos A., Erdjument-Bromage, Hediye, Olshen, Adam B., Fleisher, Martin, Lilja, Hans, Brogi, Edi, Boyd, Jeff, Sanchez-Carbayo, Marta, Holland, Eric C., Cordon-Cardo, Carlos, Scher, Howard I., Tempst, Paul
Published 2006

Lrf suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion

by Wang, Guocan, Lunardi, Andrea, Zhang, Jiangwen, Chen, Zhenbang, Ala, Ugo, Webster, Kaitlyn A., Tay, Yvonne, Gonzalez-Billalabeitia, Enrique, Egia, Ainara, Shaffer, David R., Carver, Brett, Liu, Xue-Song, Taulli, Riccardo, Kuo, Winston Patrick, Nardella, Caterina, Signoretti, Sabina, Cordon-Cardo, Carlos, Gerald, William L., Pandolfi, Pier Paolo
Published 2013

Lenvatinib in Combination With Pembrolizumab in Patients with Treatment-Naïve and Treatment-Experienced Metastatic Renal Cell Carcinoma: Results From a Phase 1b/2 Study

by Lee, Chung-Han, Shah, Amishi Yogesh, Rasco, Drew, Rao, Arpit, Taylor, Matthew H., Di Simone, Christopher, Hsieh, James J., Pinto, Alvaro, Shaffer, David R., Sarrio, Regina Girones, Cohn, Allen Lee, Vogelzang, Nicholas J., Bilen, Mehmet Asim, Ribe, Sara Gunnestad, Goksel, Musaberk, Tennøe, Øyvind Krohn, Richards, Donald, Sweis, Randy F., Courtright, Jay, Heinrich, Daniel, Jain, Sharad, Wu, Jane, Schmidt, Emmett V., Perini, Rodolfo F., Kubiak, Peter, Okpara, Chinyere E., Smith, Alan D., Motzer, Robert J.
Published in Lancet Oncol (2021)

Atezolizumab as first-line therapy in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

by Balar, Arjun V, Galsky, Matthew D, Rosenberg, Jonathan E, Powles, Thomas, Petrylak, Daniel P, Bellmunt, Joaquim, Loriot, Yohann, Necchi, Andrea, Hoffman-Censits, Jean, Perez-Gracia, Jose Luis, Dawson, Nancy A, van der Heijden, Michiel S, Dreicer, Robert, Srinivas, Sandy, Retz, Margitta M, Joseph, Richard W, Drakaki, Alexandra, Vaishampayan, Ulka N, Sridhar, Srikala S, Quinn, David I, Durán, Ignacio, Shaffer, David R, Eigl, Bernhard J, Grivas, Petros D, Yu, Evan Y, Li, Shi, Kadel, Edward E, Boyd, Zachary, Bourgon, Richard, Hegde, Priti S, Mariathasan, Sanjeev, Thåström, AnnChristine, Abidoye, Oyewale O, Fine, Gregg D, Bajorin, Dean F
Published in Lancet (2016)